1. 120TiPEORTC SPECTA-AYA: A molecular profiling platform for adolescents and young adults with cancer in Europe. (7th November 2019) Authors: de Rojas, T; Kasper, B; Van der Graaf, W; Pfister, S M; Bielle, F; Ribalta, T; Shenjere, P; Preusser, M; Fröhling, S; Morfouace, M; McCabe, M G Journal: Annals of oncology Issue: Volume 30(2019)Supplement 7 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 372OMutational and inflammatory microenvironment characteristics in primary and matched local recurrent non-small cell lung cancer brain metastases. (23rd October 2018) Authors: Berghoff, A S; Erguener, B; Schuster, M R; Rajky, U; Ricken, G; Frischer, J M; Gatterbauer, B; Marosi, C; Dieckmann, K; Widhalm, G; Bock, C; Preusser, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 379PDAndrogen receptor expression in breast cancer brain metastases. (23rd October 2018) Authors: Bergen, E S; Berghoff, A S S; Rajky, U; Rudas, M; Bago-Horvath, Z; Exner, R; Dieckmann, K; Widhalm, G; Gnant, M I; Zielinski, C C; Steger, G G; Preusser, M; Bartsch, R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Alzheimer-type neuropathology in a 28 year old patient with iatrogenic Creutzfeldt-Jakob disease after dural grafting. Issue 3 (16th February 2006) Authors: Preusser, M; Ströbel, T; Gelpi, E; Eiler, M; Broessner, G; Schmutzhard, E; Budka, H Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 77:Issue 3(2006) Page Start: 413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. C.07 Predicting individualized risk of recurrence: development and validation of a DNA-methylation based nomogram in meningioma. (5th June 2019) Authors: Nassiri, F; Mamatjan, Y; Suppiah, S; Badhiwala, J; Mansouri, S; Karimi, S; Saarela, O; Poisson, L; Ng, H; Noushmehr, H; Harter, P; Baumgarten, P; Weller, M; Preusser, M; Mende, C; Sahm, F; von Deimling, A; Aldape, K; Zadeh, G Journal: Canadian journal of neurological sciences Issue: Volume 46(2019)Supplement 1 Page Start: S13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. C.07 Predicting individualized risk of recurrence: development and validation of a DNA-methylation based nomogram in meningioma. (June 2019) Authors: Nassiri, F; Mamatjan, Y; Suppiah, S; Badhiwala, J; Mansouri, S; Karimi, S; Saarela, O; Poisson, L; Ng, H; Noushmehr, H; Harter, P; Baumgarten, P; Weller, M; Preusser, M; Mende, C; Sahm, F; von Deimling, A; Aldape, K; Zadeh, G Journal: Canadian journal of neurological sciences Issue: Volume 46(2019)Supplement 1 Page Start: S13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. JS07.4.A Correspondence of glutamine and glycine imaging based on 7T MRSI to amino acid PET. (5th September 2022) Authors: Hangel, G; Rausch, I; Furtner, J; Roetzer-Pejrimovsky, T; Preusser, M; Bogner, W; Rössler, K; Trattnig, S; Traub-Weidinger, T; Widhalm, G Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OS01.5.A Neuron-specific enolase (NSE) and S100 serum levels in patients with active brain metastases from HER2-positive breast cancer treated with trastuzumab-deruxtecan (T-DXd): A biomarker analysis from the TUXEDO-1 trial. (5th September 2022) Authors: Berghoff, A S; Bartsch, R; Furtner, J; Marhold, M; Bergen, E S; Roider-Schur, S; Starzer, A M; Forstner, H; Rottenmanner, B; Dieckmann, K; Bago-Horvath, Z; Widhalm, G; Ilhan-Mutlu, A; Minichsdorfer, C; Fuereder, T; Singer, C F; Weltermann, A; Haslacher, H; Szekeres, T; Puhr, R Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OS03.5.A Characterization of the inflammatory tumor microenvironment composition in solid cancer patients with brain metastases after progression to immune checkpoint inhibitor therapy. (5th September 2022) Authors: Starzer, A M; Kleinberger, M; Feldmann, K; Tomasich, E; Hatziioannou, T; Paiato, C; Heller, G; Kreminger, J; Traint, S; Steindl, A; Ressler, J M; Widhalm, G; Gatterbauer, B; Dieckmann, K; Müllauer, L; Preusser, M; Berghoff, A S Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OS03.7.A Clinical characteristics, treatment and long-term outcome of patients with brain metastases from thyroid cancer - an analysis of the Vienna Brain Metastasis Registry. (5th September 2022) Authors: Wolff, L; Steindl, A; Dieckmann, K; Gatterbauer, B; Widhalm, G; Berghoff, A; Preusser, M; Raderer, M; Kiesewetter, B Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗